This study, called COOL-IT-PRO, is looking at the safety of a treatment called cryoablation for breast cancer. Cryoablation uses extreme cold to destroy cancer cells. This study is for people with breast cancer who cannot have surgery because of other medical conditions, or if surgery isn't recommended for other reasons. You can join if you are 18 or older, have a breast cancer diagnosis, and your tumor can be seen on an ultrasound and is more than 5mm from your skin. The main goal is to see how many patients experience serious treatment-related problems over three years. The study status is currently unclear, and it plans to include 100 participants.

Study design

This is an observational study, meaning researchers will collect information from patients who receive cryoablation. It is a registry study, gathering data on 100 planned participants.

What's involved

Not specified in the trial record.

Compensation

Not stated in the trial record.

Follow-up

Participants will be followed for up to three years to monitor for any serious treatment-related complications.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.